- Home
- IZM vs ENLV Comparison
IZM vs ENLV Comparison
Compare IZM & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IZM | ENLV |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.2M | 26.6M |
| IPO Year | 2023 | 1995 |
Fundamental Metrics
Financial Performance| Metric | IZM | ENLV |
|---|---|---|
| Price | $2.10 | $0.84 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 193.6K | ★ 625.1K |
| Earning Date | 10-24-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $187,048,691.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $25.50 | ★ N/A |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $0.87 | $0.66 |
| 52 Week High | $2.74 | $2.10 |
Technical Indicators
Market Signals| Indicator | IZM | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 47.96 |
| Support Level | $1.80 | $0.66 |
| Resistance Level | $2.73 | $0.88 |
| Average True Range (ATR) | 0.32 | 0.06 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 64.61 | 83.27 |
Price Performance
Historical ComparisonAbout IZM ICZOOM Group Inc.
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.